Literature DB >> 25081317

Innate immune activation of NFκB and its antagonism by poxviruses.

Gareth Brady1, Andrew G Bowie2.   

Abstract

In recent years there has been an acceleration of discovery in the field of innate anti-viral immunity to the point that many of the key events in early virus sensing and the discrete anti-viral responses they trigger have been elucidated in detail. In particular, pattern recognition receptors (PRRs) that detect viruses at the plasma membrane, in endosomes, and within the cytosol have been characterized. Upon stimulation by viruses, most of these PRRs trigger signal transduction pathways culminating in NFκB activation. NFκB contributes both to type I interferon induction, and to production of pro-inflammatory cytokines from infected cells. Our understanding of host anti-viral innate immunity has been greatly aided by an appreciation of the ways in which poxviruses have evolved strategies to inhibit both innate sensing and effector responses. A recurring feature of poxviral immunomodulation is the apparent necessity for poxviruses to evolve multiple, non-redundant inhibitors of NFκB activation which often appear to act on the same innate signalling pathway. The reason for such apparent over-targeting of one transcription factor is not clear. Here we describe the current understanding of how host cells sense poxvirus infection to trigger signalling pathways leading to NFκB activation and pro-inflammatory cytokine induction, and the ways in which poxviruses have evolved to concisely antagonize these systems.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  IL-1; NFκB; Poxvirus; TNF; Viral immune evasion

Mesh:

Substances:

Year:  2014        PMID: 25081317     DOI: 10.1016/j.cytogfr.2014.07.004

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  18 in total

1.  Poxvirus Protein MC132 from Molluscum Contagiosum Virus Inhibits NF-B Activation by Targeting p65 for Degradation.

Authors:  Gareth Brady; Darya A Haas; Paul J Farrell; Andreas Pichlmair; Andrew G Bowie
Journal:  J Virol       Date:  2015-08       Impact factor: 5.103

2.  Poxviral protein E3-altered cytokine production reveals that DExD/H-box helicase 9 controls Toll-like receptor-stimulated immune responses.

Authors:  Alan Dempsey; Sinead E Keating; Michael Carty; Andrew G Bowie
Journal:  J Biol Chem       Date:  2018-08-15       Impact factor: 5.157

Review 3.  Evasion of host immune defenses by human papillomavirus.

Authors:  Joseph A Westrich; Cody J Warren; Dohun Pyeon
Journal:  Virus Res       Date:  2016-11-24       Impact factor: 3.303

4.  Molluscum Contagiosum Virus Protein MC005 Inhibits NF-κB Activation by Targeting NEMO-Regulated IκB Kinase Activation.

Authors:  Gareth Brady; Darya A Haas; Paul J Farrell; Andreas Pichlmair; Andrew G Bowie
Journal:  J Virol       Date:  2017-07-12       Impact factor: 5.103

5.  Heat-inactivated modified vaccinia virus Ankara boosts Th1 cellular and humoral immunity as a vaccine adjuvant.

Authors:  Ning Yang; Aitor Garcia; Cindy Meyer; Thomas Tuschl; Taha Merghoub; Jedd D Wolchok; Liang Deng
Journal:  NPJ Vaccines       Date:  2022-10-19       Impact factor: 9.399

Review 6.  Poxviral ankyrin proteins.

Authors:  Michael H Herbert; Christopher J Squire; Andrew A Mercer
Journal:  Viruses       Date:  2015-02-16       Impact factor: 5.048

7.  A parapoxviral virion protein inhibits NF-κB signaling early in infection.

Authors:  Sushil Khatiwada; Gustavo Delhon; Ponnuraj Nagendraprabhu; Sabal Chaulagain; Shuhong Luo; Diego G Diel; Eduardo F Flores; Daniel L Rock
Journal:  PLoS Pathog       Date:  2017-08-07       Impact factor: 6.823

8.  The PP4R1 sub-unit of protein phosphatase PP4 is essential for inhibition of NF-κB by merkel polyomavirus small tumour antigen.

Authors:  Hussein Abdul-Sada; Marietta Müller; Rajni Mehta; Rachel Toth; J Simon C Arthur; Adrian Whitehouse; Andrew Macdonald
Journal:  Oncotarget       Date:  2017-04-11

9.  Myxoma Virus dsRNA Binding Protein M029  Inhibits the Type I IFN-Induced Antiviral State in a  Highly Species-Specific Fashion.

Authors:  Masmudur M Rahman; Grant McFadden
Journal:  Viruses       Date:  2017-02-02       Impact factor: 5.048

10.  A parapoxviral virion protein targets the retinoblastoma protein to inhibit NF-κB signaling.

Authors:  Ponnuraj Nagendraprabhu; Sushil Khatiwada; Sabal Chaulagain; Gustavo Delhon; Daniel L Rock
Journal:  PLoS Pathog       Date:  2017-12-15       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.